In 2017, Titan Medical launched a feasibility and validity study for it Sport Surgical System. Celebration-based Florida Hospital Nicholson Center and New York City-based Columbia University Medical Center are the two hospitals in the U.S. spearheading the device.
Here are five things to know:
1. Titan Medical’s research and development expenses for 2017 reached $12.90 million compared to $22.58 million in 2016.
2. In June 2017, Titan Medical completed a public offering for gross proceeds of $5.58 million followed by a second closing for an additional $1.33 million.
3. Titan Medical completed a private placement involving various robotic surgeons in the U.S. that grossed $2.68 million.
4. In December 2017, Titan Medical completed another public offering totaling $17.89 million.
5. At the end of the year, the company’s cash, cash equivalents and deposits with product development service providers reached $28.67 million, as compared to $6.36 million in 2016.
More articles on MIS:
Saint Anne’s Hospital launches Globus ExcelsiusGPS for minimally invasive spine surgery: 3 insights
7 top device companies in global minimally invasive spine surgery market
Spine surgeon Dr. Michael Halperin to speak on new minimally invasive procedure: 4 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
